# Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India

Study · id `cardio:ct-nct05683301` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05683301](<https://clinicaltrials.gov/study/NCT05683301>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05683301

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1981 participants.

## Technical summary

Registry record NCT05683301. Randomized; quadruple masking; primary purpose other. Start 2022-08-30 (actual); primary completion 2024-08-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose other
- Phase: Phase 4
- Enrolled: 1981 participants (enrolled count; ClinicalTrials.gov record NCT05683301, source copy `cardio:ctgov-nct05683301-2024-10-08`, retrieved 2026-10-26)
- Started: 2022-08-30 (actual) (ClinicalTrials.gov record NCT05683301, source copy `cardio:ctgov-nct05683301-2024-10-08`, retrieved 2026-10-26)
- Primary completion: 2024-08-30 (actual) (ClinicalTrials.gov record NCT05683301, source copy `cardio:ctgov-nct05683301-2024-10-08`, retrieved 2026-10-26)
- Completion: 2024-09-22 (actual) (ClinicalTrials.gov record NCT05683301, source copy `cardio:ctgov-nct05683301-2024-10-08`, retrieved 2026-10-26)
- Countries: India (ClinicalTrials.gov record NCT05683301, source copy `cardio:ctgov-nct05683301-2024-10-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05683301-2024-10-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India
- Acronym: TOPSPIN
- Condition: Primary Hypertension
- Intervention (Drug): Amlodipine + Perindopril
- Intervention (Drug): Perindopril + Indapamide
- Intervention (Drug): Amlodipine + Indapamide
- Lead sponsor: Centre for Chronic Disease Control, India
- Lead sponsor class: OTHER
- Collaborator: All India Institute of Medical Sciences
- Collaborator class: OTHER
- Collaborator: Imperial College London
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as a collaborator: All India Institute of Medical Sciences (`cardio:org-all-india-institute-of-medical-sciences`)
- Registry lists this organization as a collaborator: Imperial College London (`cardio:org-imperial-college-london`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial (`cardio:pubmed-40715816`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b422c1552543afaf7b5c127a5a5c9737b267d68354d727598a407364709eadfd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
